The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kan, K. S.
Right arrow Articles by Stevenson, G. T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kan, K. S.
Right arrow Articles by Stevenson, G. T.
The Journal of Immunology, 2001, 166: 1320-1326.
Copyright © 2001 by The American Association of Immunologists

Thioether-Bonded Constructs of Fab'{gamma} and Fc{gamma} Modules Utilizing Differential Reduction of Interchain Disulfide Bonds1

Kwok S. Kan*, Valerie A. Anderson{dagger}, Weng S. Leong{dagger}, Andrew M. Smith{dagger}, Andrew T. Worth{ddagger} and George T. Stevenson2,{dagger}

* Biological Sciences, University of North London, London, United Kingdom; {dagger} Tenovus Research Laboratory, Southampton University Hospitals, Southampton, United Kingdom; and {ddagger} The Edward Jenner Institute for Vaccine, Compton, United Kingdom

We describe a two-stage preparation of chemically engineered Ab constructs, employing as modules Fab'{gamma} from mAb or rAb, and Fc from human normal IgG1. A multivalent, optionally multispecific F(ab')n core is formed in stage one, and one or more Fc modules added in stage two. Examples include bispecific Fab2Fc2 (for simplicity, primes and Greek letters are omitted from names of final constructs) and trivalent Fab3Fc2, which are designed to kill neoplastic cells. An essential element in the construction is the availability of the Fab' in two reduced forms, Fab'(-sulfhydryl (SH))5 and Fab'-SH. The first is obtained by full reduction of the interchain disulfide bonds (SS) in the F(ab')2 fragment of IgG. Fab'-SH is obtained by disulfide-interchange reactions on Fab'(-SH)5, whereby the {gamma}-light SS is reconstituted, an unusual intrachain SS forms in the {gamma}-chain hinge, and one hinge SH remains. F(ab')2 and F(ab')3 cores are built using partially reduced modules, being given intermodular thioether links that resist reduction. These cores are then fully reduced, making available SH groups for addition of the Fc{gamma} modules. In the final constructs, all intermodular links embody tandem thioether bonds arising at hinge-region cysteines. Cytotoxic activities of representative constructs, and some enhancements deriving from multiple modules, are assessed. In guinea pigs, catabolism of Fab2Fc2 yielded a t1/2 similar to that of human IgG1, although the serum Fab2Fc2 revealed some proteolytic breakdown not shown by the IgG1. Immunotherapy of a guinea-pig leukemia confirmed the ability of these constructs to kill target cells in vivo.




This article has been cited by other articles:


Home page
J. Immunol.Home page
K. Miller, G. Meng, J. Liu, A. Hurst, V. Hsei, W.-L. Wong, R. Ekert, D. Lawrence, S. Sherwood, L. DeForge, et al.
Design, Construction, and In Vitro Analyses of Multivalent Antibodies
J. Immunol., May 1, 2003; 170(9): 4854 - 4861.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2001 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2001 by The American Association of Immunologists, Inc. All rights reserved.